MARCUZZI, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 4.467
AS - Asia 2.412
EU - Europa 1.303
SA - Sud America 595
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 8.838
Nazione #
US - Stati Uniti d'America 4.378
SG - Singapore 1.085
CN - Cina 544
BR - Brasile 495
PL - Polonia 475
HK - Hong Kong 298
IT - Italia 262
VN - Vietnam 256
DE - Germania 115
GB - Regno Unito 96
RU - Federazione Russa 93
ID - Indonesia 76
FR - Francia 61
UA - Ucraina 52
AR - Argentina 43
MX - Messico 40
CA - Canada 32
TR - Turchia 30
IN - India 29
NL - Olanda 29
FI - Finlandia 28
ZA - Sudafrica 27
BD - Bangladesh 25
AT - Austria 22
SE - Svezia 16
ES - Italia 14
EC - Ecuador 13
JP - Giappone 11
CO - Colombia 9
IE - Irlanda 9
PY - Paraguay 9
UZ - Uzbekistan 9
IQ - Iraq 8
CL - Cile 7
DO - Repubblica Dominicana 7
LT - Lituania 7
PK - Pakistan 7
CZ - Repubblica Ceca 6
KE - Kenya 6
VE - Venezuela 6
BO - Bolivia 5
MA - Marocco 4
SN - Senegal 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
BA - Bosnia-Erzegovina 3
BE - Belgio 3
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
TW - Taiwan 3
AO - Angola 2
CH - Svizzera 2
DZ - Algeria 2
GA - Gabon 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
TO - Tonga 1
Totale 8.838
Città #
Fairfield 685
Ashburn 551
Singapore 520
Warsaw 471
Woodbridge 355
Hong Kong 297
Santa Clara 296
Seattle 272
Houston 262
Beijing 253
Cambridge 239
Wilmington 207
Dallas 143
Ann Arbor 85
Ho Chi Minh City 85
Princeton 73
Ferrara 70
Los Angeles 68
Jakarta 60
Chandler 59
Hanoi 53
São Paulo 51
New York 50
San Diego 47
Moscow 45
Chicago 43
Munich 37
Shanghai 37
Jacksonville 34
London 33
Nuremberg 25
Mexico City 24
Milan 21
Dong Ket 20
Rio de Janeiro 19
Buffalo 17
Jinan 17
Nanjing 17
Bologna 16
Brooklyn 16
Montreal 16
Johannesburg 15
Atlanta 14
Chennai 14
Haiphong 14
Amsterdam 13
Boardman 13
Denver 13
Poplar 13
Salt Lake City 13
Aprilia 12
Izmir 12
Orem 12
Stockholm 12
Falls Church 11
Boston 10
Boydton 10
Changsha 10
Hải Dương 10
Manchester 10
Shenyang 10
Tokyo 10
Ankara 9
Belo Horizonte 9
Redwood City 9
Tashkent 9
Turku 9
Assago 8
Brasília 8
Campinas 8
Norwalk 8
Perugia 8
Rome 8
The Dalles 8
Curitiba 7
Frankfurt am Main 7
Hebei 7
Hefei 7
Helsinki 7
Hounslow 7
Mountain View 7
Vienna 7
Buenos Aires 6
Council Bluffs 6
Da Nang 6
Dublin 6
Ferrara di Monte Baldo 6
Nanchang 6
Paris 6
Phoenix 6
São José dos Campos 6
Tianjin 6
Bogotá 5
Columbus 5
Cotia 5
Elk Grove Village 5
Lanzhou 5
Las Vegas 5
Quito 5
Recife 5
Totale 6.197
Nome #
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children 358
Neuronal dysfunction associated with cholesterol deregulation 247
Cytokine levels in the serum of healthy subjects 217
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 188
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 183
Type I interferon-mediated autoinflammation due to DNase II deficiency 183
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 179
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 169
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 165
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 159
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 157
A common genetic background could explain early-onset Crohn's disease 144
Alendronate, a double-edged sword acting in the mevalonate pathway 140
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 140
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011) 136
Putative modifier genes in mevalonate kinase deficiency 135
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration 131
Innovative target therapies are able to block the inflammation associated with dysfunction of the cholesterol biosynthesis pathway 130
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 130
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 126
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 126
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency 126
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide 125
Clinical Genetic Testing of Periodic Fever Syndromes 125
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 122
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al 121
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 121
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 120
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line 120
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 117
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 117
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 116
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 116
The effect of clodronate on a mevalonate kinase deficiency cellular model 115
Database tools in genetic diseases research 115
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 113
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 112
Role of vitamin D in the pathogenesis of atheromatosis 112
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 110
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 109
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes 107
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 106
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 102
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 102
Presence of IL-9 in paired samples of human colostrum and transitional milk 102
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 97
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 97
Inflammation profile of four early onset Crohn patients 93
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 93
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 90
Serum amyloid A and cholesterol: a pivotal role on inflammation 89
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 86
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes 86
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency 86
Mevalonate kinase deficiency and IBD: shared genetic background 86
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders 85
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency 82
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation 81
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 79
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 76
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 75
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 75
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis 74
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches 73
Evolutionary hypothesis of the Mevalonate Kinase Deficiency 72
New Mechanisms in Autoinflammatory Diseases 72
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 71
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 69
MitoQ is able to modulate apoptosis and inflammation 69
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 68
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 66
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 65
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 63
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 59
Mevalonate kinase deficiency: Disclosing the role of mevalonate pathway modulation in inflammation 53
Post-irradiation hyperamylasemia is a prognostic marker for allogeneic hematopoietic stem cell transplantation outcomes in pediatric population: A retrospective single-centre cohort analysis 52
Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches 49
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 49
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study 45
Long non-coding RNA GAS5 and intestinal MMP2 and MMP9 expression: A translational study in pediatric patients with IBD 43
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 42
Family history in early-onset inflammatory bowel disease 41
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 38
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 36
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 11
Totale 9.030
Categoria #
all - tutte 56.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021759 0 0 0 0 0 157 97 141 54 202 41 67
2021/2022485 37 36 15 12 11 49 41 40 20 71 22 131
2022/2023310 85 9 19 14 15 24 14 17 47 4 43 19
2023/2024373 33 38 28 9 32 22 20 22 16 20 18 115
2024/20251.776 27 37 168 67 218 158 56 67 266 316 279 117
2025/20263.012 422 388 474 766 720 242 0 0 0 0 0 0
Totale 9.030